Skip to Content
Merck
All Photos(2)

Key Documents

View All Documentation

Safety Information

101273

Sigma-Aldrich

2-Bromo-4′-chloroacetophenone

98%

Synonym(s):

ω-Bromo-4-chloroacetophenone, 4-Chlorophenacyl bromide

Sign Into View Organizational & Contract Pricing

Select a Size

25 G
¥5,880
100 G
¥20,200

¥5,880

Check Cart for Availability
Request a Bulk Order
All Photos(2)

Select a Size

Change View
25 G
¥5,880
100 G
¥20,200

About This Item

Linear Formula:
ClC6H4COCH2Br
CAS Number:
536-38-9
Molecular Weight:
233.49
Beilstein:
607603
EC Number:
208-631-5
MDL number:
MFCD00000625
UNSPSC Code:
12352100
PubChem Substance ID:
24846535
NACRES:
NA.22

¥5,880

Check Cart for Availability
Request a Bulk Order

Quality Level

100

Assay

98%

form

solid

mp

93-96 °C (lit.)

functional group

bromo
chloro
ketone

SMILES string

Clc1ccc(cc1)C(=O)CBr

InChI

1S/C8H6BrClO/c9-5-8(11)6-1-3-7(10)4-2-6/h1-4H,5H2

InChI key

FLAYZKKEOIAALB-UHFFFAOYSA-N

Looking for similar products? Visit Product Comparison Guide

Related Categories

Pictograms

Exclamation mark
GHS07

Signal Word

Warning

Hazard Statements

H302,H315,H319,H335

Hazard Classifications

Acute Tox. 4 Oral - Eye Irrit. 2 - Skin Irrit. 2 - STOT SE 3

Target Organs

Respiratory system

Storage Class Code

11 - Combustible Solids

WGK

WGK 3

Flash Point(F)

Not applicable

Flash Point(C)

Not applicable

Personal Protective Equipment

dust mask type N95 (US), Eyeshields, Gloves

Regulatory Listings

Regulatory Listings are mainly provided for chemical products. Only limited information can be provided here for non-chemical products. No entry means none of the components are listed. It is the user’s obligation to ensure the safe and legal use of the product.

JAN Code

101273-100G:
101273-VAR:
101273-BULK:
101273-25G:

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number
0000396475
0000396475
0000204287
0000209701
0000178100

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Search for a COA

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Daniel I Perez et al.
Journal of medicinal chemistry, 54(12), 4042-4056 (2011-04-20)
Development of kinase-targeted therapies for central nervous system (CNS) diseases is a great challenge. Glycogen synthase kinase 3 (GSK-3) offers a great potential for severe CNS unmet diseases, being one of the inhibitors on clinical trials for different tauopathies. Following
Shigeo Hayashi et al.
Journal of enzyme inhibition and medicinal chemistry, 29(6), 846-867 (2014-02-13)
Because of the pivotal role of cyclooxygenase (COX) in the inflammatory processes, non-steroidal anti-inflammatory drugs (NSAIDs) that suppress COX activities have been used clinically for the treatment of inflammatory diseases/syndromes; however, traditional NSAIDs exhibit serious side-effects such as gastrointestinal damage

Questions

Reviews

No rating value

Active Filters

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service